PAIA Biotech GmbH offers assays for the rapid quantification of antibodies and proteins based on its proprietary assay technology. It features bead-based immunoassays with fluorescence detection in specially designed 384-well microplates which drastically simplify the workflow. The assays are amenable to automation and run on standard plate readers or fluorescence microscopes. PAIA Biotech focuses on products for screening applications with limited sample volume and high throughput requirements, e.g. in early cell line development.
In addition to off-the-shelf products for IgG and IgG fragments PAIA Biotech GmbH also offers custom assay development. PAIA Biotech GmbH was founded in 2014 and is based at the RTZ in Cologne.
PAIA Biotech GmbH